Rare Diseases
Volume 1, 2013 - Issue 1
Open access
894
Views
13
CrossRef citations to date
0
Altmetric
Addendum
GSK3β is a new therapeutic target for myotonic dystrophy type 1
Christina Wei Department of Molecular Physiology and Biophysics; Baylor College of Medicine; Houston, TX USA
, Karlie Jones Department of Molecular Physiology and Biophysics; Baylor College of Medicine; Houston, TX USA
, Nikolai A Timchenko Pathology and Immunology; Huffington Center on Aging; Baylor College of Medicine; Houston, TX USA
& Lubov Timchenko Department of Molecular Physiology and Biophysics; Baylor College of Medicine; Houston, TX USACorrespondence[email protected]
Article: e26555
|
Received 31 Jul 2013, Accepted 20 Sep 2013, Published online: 26 Sep 2013
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.